跳至主要内容
临床试验/NCT01361386
NCT01361386已完成不适用

Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia

AstraZeneca1 个研究点 分布在 1 个国家目标入组 13,011 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
13,011
试验地点
1
主要终点
short- and long-term medication and treatment prescribed by physicians in real-life setting

研究概览

简要总结

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent has been provided.
  • Diagnosis of STEMI, NSTEMI or UA
  • Hospitalization for the first time within 48 hours of onset of symptoms.

排除标准

  • UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
  • Current participation in a randomised interventional clinical trial.

结局指标

主要结局

short- and long-term medication and treatment prescribed by physicians in real-life setting

时间窗: up to 3 years

次要结局

  • clinical outcome (Cardiovascular events)(up to 3 years)
  • quality of life (EQ-5D questionnaire)(up to 3 years)
  • cost of hospitalization(up to 3 years)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验